Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.43 +0.02 (+1.43%)
As of: Nov 11, 2026 · 10:51 AM EST

Tvardi Therapeutics (TVRD) Accumulated Expenses (2024 - 2026)

Updated

Tvardi Therapeutics' Accumulated Expenses was $4.35 million in Q2 2026, down 46.6% from $8.14 million a year earlier and down 33.2% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Tvardi Therapeutics came in at $7.71 million, down 4.6% from FY2024.

  • In earlier years, Accumulated Expenses was $8.08 million in FY2024.
  • Per Business Quant data, TVRD's Accumulated Expenses in the three quarters before Q2 2026 was $6.52 million (Q1 2026), $7.71 million (Q4 2025) and $6.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tvardi Therapeutics 13.23 Mn -94.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.35 Mn
Mar 31, 2026 6.52 Mn
Dec 31, 2025 7.71 Mn
Sep 30, 2025 6.85 Mn
Jun 30, 2025 8.14 Mn
Dec 31, 2024 8.08 Mn
API Access

Tvardi Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TVRD&period=max&api_key=YOUR_API_KEY